Dr John Studley (JS) from Scientific Update spoke to Dr David Barnes (DB) from Abbvie in the US  ahead of our ‘Organic Process Research and Development’ Conference which is taking place in Clearwater, Florida on 9-11 March. We are looking forward to your presentation ‘Discovery of Novel Catalytic Technologies in the Development of Complex Clinical

We had a fantastic turn out for our #OPRDUS18 Conference in Clearwater, Florida last month. It was great to see our speakers, exhibitors and attendees and the feedback we received was excellent. Thank you for coming along! Our Technical Director Dr Will Watson opened the conference and we invited Dr Paul Murray and Dr André de

Permissible limits for impurities during clinical development has always been a grey area. Existing guidelines, specifically ICH Q3A only formally apply to marketed products. How factors such as duration of clinical trials have never been effectively addressed.